论文部分内容阅读
过去几年中,在内窥镜直视下行曲张静脉硬化剂治疗(EVS)已成为食管静脉曲张破裂出血的主要治疗方法.多次研究均证实接受长期EVS者再出血率降低.EVS少见而严重的并发症包括食管穿孔、出血加重、严重肺炎和食管狭窄等.较轻而常见的并发症有发热、胸痛、胸膜渗出、咽下困难、咽痛,一般持续不到48小时.本文拟确定EVS后胸膜渗出的发生与硬化剂剂量的关系及胸水的生化性质.30例病人共65人次在治疗前24小时内及治疗后72小时内拍摄了后前位、侧位或床旁前后位胸片.其中21例为酒精性肝硬化,9例为其它各种类型的肝硬化.42人次是因曲张静脉出血或其它慢性肝病并发症入院,23人次仅因作EVS而入
Over the past few years, the treatment of variceal sclerosis (EVS) has been the primary treatment of esophageal variceal bleeding in endoscopic direct vision, and repeated studies have shown that rebleeding rates are reduced in patients receiving long-term EVS. Complications include esophageal perforation, bleeding, severe pneumonia and esophageal stenosis, etc. The lesser and common complications are fever, chest pain, pleural exudate, dysphagia, sore throat, usually lasted less than 48 hours.This paper is to determine EVS after the occurrence of pleural effusion and the relationship between the dose of sclerosing agent and the biochemical properties of pleural effusion .30 patients a total of 65 people within 24 hours before treatment and after 72 hours after treatment of posterior, lateral or bedside anteroposterior Of these, 21 were alcoholic cirrhosis and 9 were other types of cirrhosis.42 were hospitalized for variceal hemorrhage or other complications of chronic liver disease, 23 were admitted for EVS only